Bausch Health Cos Goodwill and Intangible Assets 2010-2024 | BHC

Bausch Health Cos goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Bausch Health Cos Annual Goodwill and Intangible Assets
(Millions of US $)
2023 $17,639
2022 $17,347
2021 $19,405
2020 $21,489
2019 $23,327
2018 $25,143
2017 $30,804
2016 $34,678
2015 $41,636
2014 $20,639
2013 $22,600
2012 $14,450
2011 $11,223
2010 $9,374
2009 $1,436
Bausch Health Cos Quarterly Goodwill and Intangible Assets
(Millions of US $)
2024-09-30 $16,823
2024-06-30 $17,030
2024-03-31 $17,343
2023-12-31 $17,639
2023-09-30 $17,915
2023-06-30 $16,927
2023-03-31 $17,131
2022-12-31 $17,347
2022-09-30 $18,068
2022-06-30 $18,588
2022-03-31 $19,059
2021-12-31 $19,405
2021-09-30 $19,735
2021-06-30 $20,151
2021-03-31 $20,482
2020-12-31 $21,489
2020-09-30 $22,083
2020-06-30 $22,381
2020-03-31 $22,760
2019-12-31 $23,327
2019-09-30 $23,702
2019-06-30 $24,356
2019-03-31 $24,804
2018-12-31 $25,143
2018-09-30 $25,945
2018-06-30 $26,676
2018-03-31 $27,896
2017-12-31 $30,804
2017-09-30 $31,596
2017-06-30 $33,408
2017-03-31 $33,939
2016-12-31 $34,678
2016-09-30 $37,960
2016-06-30 $39,848
2016-03-31 $40,947
2015-12-31 $41,636
2015-09-30 $39,757
2015-06-30 $40,383
2015-03-31 $20,716
2014-12-31 $20,639
2014-09-30 $21,088
2014-06-30 $21,188
2014-03-31 $22,618
2013-12-31 $22,600
2013-09-30 $22,832
2013-06-30 $14,567
2013-03-31 $14,393
2012-12-31 $14,450
2012-09-30 $11,835
2012-06-30 $11,846
2012-03-31 $11,539
2011-12-31 $11,223
2011-09-30 $10,212
2011-06-30 $10,319
2011-03-31 $9,885
2010-12-31 $9,374
2010-09-30 $9,435
2010-06-30 $1,364
2010-03-31 $1,400
2009-12-31 $1,436
2009-09-30 $1,480
2009-06-30 $1,515
2009-03-31 $803
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.009B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00